Your browser doesn't support javascript.
loading
Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial.
Joensuu, Heikki; Kellokumpu-Lehtinen, Pirkko-Liisa; Huovinen, Riikka; Jukkola-Vuorinen, Arja; Tanner, Minna; Kokko, Riitta; Ahlgren, Johan; Auvinen, Päivi; Lahdenperä, Outi; Kosonen, Sanna; Villman, Kenneth; Nyandoto, Paul; Nilsson, Greger; Poikonen-Saksela, Paula; Kataja, Vesa; Junnila, Jouni; Bono, Petri; Lindman, Henrik.
Afiliação
  • Joensuu H; Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Kellokumpu-Lehtinen PL; Department of Oncology, Tampere University Hospital and University of Tampere, Tampere, Finland.
  • Huovinen R; Department of Oncology, Turku University Central Hospital, Turku, Finland.
  • Jukkola-Vuorinen A; Department of Oncology and Radiotherapy, Oulu University Hospital, Oulu, Finland.
  • Tanner M; Department of Oncology, Tampere University Hospital and University of Tampere, Tampere, Finland.
  • Kokko R; Kanta-Häme Central Hospital, Hämeenlinna, Finland.
  • Ahlgren J; Gävle Hospital, Gävle, Sweden.
  • Auvinen P; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
  • Lahdenperä O; Department of Oncology, Turku University Central Hospital, Turku, Finland.
  • Kosonen S; Kotka Central Hospital, Kotka, Finland.
  • Villman K; Örebro University Hospital, Örebro, Sweden.
  • Nyandoto P; Päijät-Häme Central Hospital, Lahti, Finland.
  • Nilsson G; Uppsala University Hospital, Uppsala, Sweden.
  • Poikonen-Saksela P; Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Kataja V; Cancer Center, Kuopio University Hospital, Kuopio, Finland12Vaasa Central Hospital, Vaasa, Finland.
  • Junnila J; 4Pharma, Turku, Finland.
  • Bono P; Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Lindman H; Uppsala University Hospital, Uppsala, Sweden.
JAMA Oncol ; 3(6): 793-800, 2017 Jun 01.
Article em En | MEDLINE | ID: mdl-28253390
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Mama Triplo Negativas Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: JAMA Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Finlândia País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Mama Triplo Negativas Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: JAMA Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Finlândia País de publicação: Estados Unidos